Sales Trigger: NTx Hires RNA Biology Pioneer

🚀 Battle Card: NTx

• Dr. Jeff Coller, Scientific Advisory Board Member · 🔗 LinkedIn

• This NTx sales trigger signals a strategic push to deepen expertise in RNA biology for scalable therapeutic platforms. → Source

• Scaling RNA and protein manufacturing from R&D to mass production

• Translating cutting-edge RNA biology research into robust, compliant processes

• Primary: RNA Manufacturing Automation → Accelerate scale-up and reduce production errors

• Expansion: Protein Production Analytics → Optimize yield and cut operating costs

• HQ: Rio Rancho, NM

• Employees: ≈ 75

• Rev: ≈ $10M

• Website: ntxbio.com

🤼 Competitive Intel

• Thermo Fisher Scientific — RNA Production Platforms
• Unique edge: End-to-end reagent kits and workflows
• Evaluated by VP Ops & Dir. Bioprocessing for reliability

• Sartorius — Bioprocess Systems
• Unique edge: Integrated single-use biomanufacturing solutions
• Evaluated by COO & VP Manufacturing for scale potential

• Cytiva — Single-Use Biomanufacturing
• Unique edge: Modular, disposable technologies
• Evaluated by Dir. Engineering & QA for flexibility

• Catalent — Biologics Contract Manufacturing
• Unique edge: End-to-end development-to-commercialization services
• Evaluated by CFO & VP Strategy for cost-efficiency

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑<your company>❑
OFFER_BRIEF   = ❑<1-line value>❑
PROOF_METRIC  = ❑<metric>❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly | punchy❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Jeff
COMPANY     = NTx
DEPT        = ≈ TBD
SIZE        = ≈ 75
BOTTLENECK  = Scaling RNA and protein manufacturing from R&D to mass production
EVENT       = Appointment of RNA Biology Pioneer Dr. Jeff Coller
DETAIL      = Expands Scientific Advisory Board with Appointment of RNA Biology Pioneer Dr. Jeff Coller
PAIN        = Translating cutting-edge RNA biology research into robust, compliant processes
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250916399949&div=41152219
SIM_CO      = ≈ TBD
WIN_METRIC  = ≈ TBD
NEXT_SIZE   = ≈ 150
EMP_EST     = ≈ 75
REV_EST     = ≈ $10M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈ 75-person ≈ TBD

Jeff—noticed your ≈ TBD team is ≈ 75.

That’s when Scaling RNA and protein manufacturing from R&D to mass production slows growth.

We helped ≈ TBD fix this with ❑<1-line value>❑.

Result: ≈ TBD.  
Quick call?

PS—next bottleneck hits ≈ 150.

DM ≤45 words, TONE:
Saw your post about Expands Scientific Advisory Board with Appointment of RNA Biology Pioneer Dr. Jeff Coller — Translating cutting-edge RNA biology research into robust, compliant processes.  
❑<1-line value>❑. ❑<metric>❑.  
Quick chat?